Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

NCT00311584 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

NETWORK

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: irinotecan hydrochloride
DRUG: temozolomide

Sponsor

Children's Oncology Group

Collaborators

[object Object]